The Neck Region of the C-type Lectin DC-SIGN Regulates Its Surface Spatiotemporal Organization and Virus-binding Capacity on Antigen-presenting Cells*

Background: Nanoclusters of the C-type lectin DC-SIGN on dendritic cells act as docking sites for viral binding. Results: The extracellular neck region is responsible for nanocluster formation and necessary for virus binding. Conclusion: Heterogeneous nanocluster density and spatial distribution confer broad binding capabilities to DC-SIGN. Significance: Insights into how virus receptors preorganize and assemble into docking platforms contribute to clarifying mechanisms of virus entry. The C-type lectin DC-SIGN expressed on dendritic cells (DCs) facilitates capture and internalization of a plethora of different pathogens. Although it is known that DC-SIGN organizes in nanoclusters at the surface of DCs, the molecular mechanisms responsible for this well defined nanopatterning and role in viral binding remain enigmatic. By combining biochemical and advanced biophysical techniques, including optical superresolution and single particle tracking, we demonstrate that DC-SIGN intrinsic nanoclustering strictly depends on its molecular structure. DC-SIGN nanoclusters exhibited free, Brownian diffusion on the cell membrane. Truncation of the extracellular neck region, known to abrogate tetramerization, significantly reduced nanoclustering and concomitantly increased lateral diffusion. Importantly, DC-SIGN nanocluster dissolution exclusively compromised binding to nanoscale size pathogens. Monte Carlo simulations revealed that heterogeneity on nanocluster density and spatial distribution confers broader binding capabilities to DC-SIGN. As such, our results underscore a direct relationship between spatial nanopatterning, driven by intermolecular interactions between the neck regions, and receptor diffusion to provide DC-SIGN with the exquisite ability to dock pathogens at the virus length scale. Insight into how virus receptors are organized prior to virus binding and how they assemble into functional platforms for virus docking is helpful to develop novel strategies to prevent virus entry and infection.

[1]  W. Weis,et al.  Extended Neck Regions Stabilize Tetramers of the Receptors DC-SIGN and DC-SIGNR* , 2005, Journal of Biological Chemistry.

[2]  Ari Helenius,et al.  DC-SIGN as a receptor for phleboviruses. , 2011, Cell host & microbe.

[3]  C. Figdor,et al.  Identification of DC-SIGN, a Novel Dendritic Cell–Specific ICAM-3 Receptor that Supports Primary Immune Responses , 2000, Cell.

[4]  Kenneth A. Taylor,et al.  Electron tomography analysis of envelope glycoprotein trimers on HIV and simian immunodeficiency virus virions , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Carl G. Figdor,et al.  DC-SIGN–ICAM-2 interaction mediates dendritic cell trafficking , 2000, Nature Immunology.

[6]  Derek Toomre,et al.  Spatial control of EGF receptor activation by reversible dimerization on living cells , 2010, Nature.

[7]  R. Steinman,et al.  The dendritic cell system and its role in immunogenicity. , 1991, Annual review of immunology.

[8]  Alessandra Cambi,et al.  Nanoscale organization of the pathogen receptor DC-SIGN mapped by single-molecule high-resolution fluorescence microscopy. , 2007, Chemphyschem : a European journal of chemical physics and physical chemistry.

[9]  Carl G. Figdor,et al.  Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting , 2007, Nature Reviews Immunology.

[10]  Alessandra Cambi,et al.  The C‐type lectin DC‐SIGN (CD209) is an antigen‐uptake receptor for Candida albicans on dendritic cells , 2003, European journal of immunology.

[11]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[12]  Á. Corbí,et al.  Structural Requirements for Multimerization of the Pathogen Receptor Dendritic Cell-specific ICAM3-grabbing Non-integrin (CD209) on the Cell Surface* , 2008, Journal of Biological Chemistry.

[13]  R. Steinman,et al.  In Vivo Targeting of Antigens to Maturing Dendritic Cells via the DEC-205 Receptor Improves T Cell Vaccination , 2004, The Journal of experimental medicine.

[14]  Monique Nijhuis,et al.  Microdomains of the C-type lectin DC-SIGN are portals for virus entry into dendritic cells , 2004, The Journal of cell biology.

[15]  M. McElrath,et al.  Most DC-SIGNR transcripts at mucosal HIV transmission sites are alternatively spliced isoforms , 2005, European Journal of Human Genetics.

[16]  G. Bakker,et al.  Lateral mobility of individual integrin nanoclusters orchestrates the onset for leukocyte adhesion , 2012, Proceedings of the National Academy of Sciences.

[17]  T. Geijtenbeek,et al.  Measles Virus Targets DC-SIGN To Enhance Dendritic Cell Infection , 2006, Journal of Virology.

[18]  C. Figdor,et al.  Ligand-conjugated quantum dots monitor antigen uptake and processing by dendritic cells. , 2007, Nano letters.

[19]  J. Henley,et al.  Lateral Diffusion Drives Constitutive Exchange of AMPA Receptors at Dendritic Spines and Is Regulated by Spine Morphology , 2006, The Journal of Neuroscience.

[20]  B. Bartosch,et al.  C-type Lectins L-SIGN and DC-SIGN Capture and Transmit Infectious Hepatitis C Virus Pseudotype Particles* , 2004, Journal of Biological Chemistry.

[21]  G. Nabel,et al.  Leukocyte-specific protein 1 interacts with DC-SIGN and mediates transport of HIV to the proteasome in dendritic cells , 2007, The Journal of experimental medicine.

[22]  Ira Mellman,et al.  Cell biology of antigen processing in vitro and in vivo. , 2005, Annual review of immunology.

[23]  Daniel A. Mitchell,et al.  A Novel Mechanism of Carbohydrate Recognition by the C-type Lectins DC-SIGN and DC-SIGNR , 2001, The Journal of Biological Chemistry.

[24]  S. Gringhuis,et al.  Carbohydrate-specific signaling through the DC-SIGN signalosome tailors immunity to Mycobacterium tuberculosis, HIV-1 and Helicobacter pylori , 2009, Nature Immunology.

[25]  Maureen E. Taylor,et al.  Autonomous Tetramerization Domains in the Glycan-binding Receptors DC-SIGN and DC-SIGNR , 2009, Journal of Molecular Biology.

[26]  K. Jacobson,et al.  Super-resolution imaging of C-type lectin and influenza hemagglutinin nanodomains on plasma membranes using blink microscopy. , 2012, Biophysical journal.

[27]  Á. Corbí,et al.  C-Type Lectins DC-SIGN and L-SIGN Mediate Cellular Entry by Ebola Virus in cis and in trans , 2002, Journal of Virology.

[28]  Douglas S Kwon,et al.  DC-SIGN, a Dendritic Cell–Specific HIV-1-Binding Protein that Enhances trans-Infection of T Cells , 2000, Cell.

[29]  T. Geijtenbeek,et al.  Mycobacteria Target DC-SIGN to Suppress Dendritic Cell Function , 2003, The Journal of experimental medicine.

[30]  Alessandra Cambi,et al.  Dual function of C-type lectin-like receptors in the immune system. , 2003, Current opinion in cell biology.

[31]  D. Leckband,et al.  Binding-site geometry and flexibility in DC-SIGN demonstrated with surface force measurements , 2009, Proceedings of the National Academy of Sciences.

[32]  R. Doms,et al.  DC-SIGN Interactions with Human Immunodeficiency Virus: Virus Binding and Transfer Are Dissociable Functions , 2001, Journal of Virology.

[33]  Ken Jacobson,et al.  Distribution and lateral mobility of DC-SIGN on immature dendritic cells–implications for pathogen uptake , 2008, Journal of Cell Science.

[34]  C. Théry,et al.  The cell biology of antigen presentation in dendritic cells. , 2001, Current opinion in immunology.

[35]  S. Depraetere,et al.  Hepatitis C Virus Targets DC-SIGN and L-SIGN To Escape Lysosomal Degradation , 2004, Journal of Virology.

[36]  K. Jacobson,et al.  The Formation and Stability of DC‐SIGN Microdomains Require its Extracellular Moiety , 2012, Traffic.

[37]  U. Khoo,et al.  DC-SIGN and L-SIGN: the SIGNs for infection , 2008, Journal of Molecular Medicine.

[38]  C. Figdor,et al.  Near‐field scanning optical microscopy in liquid for high resolution single molecule detection on dendritic cells , 2004, FEBS letters.

[39]  N. Longo,et al.  Regulated Expression of the Pathogen Receptor Dendritic Cell-specific Intercellular Adhesion Molecule 3 (ICAM-3)-grabbing Nonintegrin in THP-1 Human Leukemic Cells, Monocytes, and Macrophages* , 2004, Journal of Biological Chemistry.

[40]  G. Whittaker,et al.  Utilization of DC-SIGN for Entry of Feline Coronaviruses into Host Cells , 2008, Journal of Virology.

[41]  R. Steinman,et al.  Epitope mapping on the dendritic cell-specific ICAM-3-grabbing non-integrin (DC-SIGN) pathogen-attachment factor. , 2010, Molecular immunology.

[42]  R. Doms,et al.  DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells. , 2003, Virology.

[43]  W. Weis,et al.  Structural Basis for Selective Recognition of Oligosaccharides by DC-SIGN and DC-SIGNR , 2001, Science.

[44]  C. Rinaldo,et al.  Human Herpesvirus 8 Infects and Replicates in Primary Cultures of Activated B Lymphocytes through DC-SIGN , 2008, Journal of Virology.

[45]  Enrico Gratton,et al.  DC-SIGN and influenza hemagglutinin dynamics in plasma membrane microdomains are markedly different. , 2011, Biophysical journal.

[46]  R. Waugh,et al.  Membrane mobility of beta2 integrins and rolling associated adhesion molecules in resting neutrophils. , 2008, Biophysical journal.

[47]  C. Figdor,et al.  Targeting DC-SIGN via its neck region leads to prolonged antigen residence in early endosomes, delayed lysosomal degradation, and cross-presentation. , 2011, Blood.

[48]  D. Weissman,et al.  Constitutive and induced expression of DC‐SIGN on dendritic cell and macrophage subpopulations in situ and in vitro , 2002, Journal of leukocyte biology.

[49]  Y. Kooyk,et al.  DC-SIGN: escape mechanism for pathogens , 2003, Nature Reviews Immunology.

[50]  C. Figdor,et al.  The C‐type lectin DC‐SIGN internalizes soluble antigens and HIV‐1 virions via a clathrin‐dependent mechanism , 2009, European journal of immunology.